320 related articles for article (PubMed ID: 30796500)
1. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J
Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application.
Yang F; Zhao LN; Sun Y; Chen Z
J Int Med Res; 2019 May; 47(5):1817-1828. PubMed ID: 30958071
[TBL] [Abstract][Full Text] [Related]
3. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
Doing AH; Renlund DG; Smith RA
J Heart Lung Transplant; 2002 Apr; 21(4):496-8. PubMed ID: 11927228
[TBL] [Abstract][Full Text] [Related]
4. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy.
Hor KN; Mah ML; Johnston P; Cripe TP; Cripe LH
Neuromuscul Disord; 2018 Sep; 28(9):711-716. PubMed ID: 30064893
[TBL] [Abstract][Full Text] [Related]
5. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
van Baalen A; von Spiczak S; Stephani U; Fischer G
Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
[No Abstract] [Full Text] [Related]
6. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
[No Abstract] [Full Text] [Related]
7. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.
Altenberger J; Gustafsson F; Harjola VP; Karason K; Kindgen-Milles D; Kivikko M; Malfatto G; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
J Cardiovasc Pharmacol; 2018 Mar; 71(3):129-136. PubMed ID: 28817484
[TBL] [Abstract][Full Text] [Related]
8. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
Bouchez S; Fedele F; Giannakoulas G; Gustafsson F; Harjola VP; Karason K; Kivikko M; von Lewinski D; Oliva F; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
Cardiovasc Drugs Ther; 2018 Dec; 32(6):617-624. PubMed ID: 30402660
[TBL] [Abstract][Full Text] [Related]
10. High effectiveness of repeated levosimendan cycles in a patient with advanced heart failure.
Rodríguez-Santamarta M; Sayago I; López J
Med Clin (Barc); 2017 Sep; 149(5):226. PubMed ID: 28641880
[No Abstract] [Full Text] [Related]
11. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
Kuno A; Tanno M; Horio Y
Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180
[TBL] [Abstract][Full Text] [Related]
12. Decompensated congestive heart failure - treatment with levosimendan.
Buzzini RF; Silvinato A; Floriano I; Bernardo WM; Almeida GR
Rev Assoc Med Bras (1992); 2019 May; 65(4):524-529. PubMed ID: 31066804
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan as bridge to transplant in patients with advanced heart failure.
Ponz de Antonio I; de Juan Bagudá JS; Rodríguez Chaverri A; García-Cosío Carmena MD; Arribas Ynsaurriaga F; Delgado Jiménez JF
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):422-424. PubMed ID: 32061565
[No Abstract] [Full Text] [Related]
14. Markedly High B-type Natriuretic Peptide Level in a Patient with Duchenne Muscular Dystrophy and Left Ventricular Non-Compaction.
Misumi I; Nishida Y; Honda T; Kurokawa H; Yasuda H; Kaikita K; Hokimoto S; Ogawa H
Intern Med; 2015; 54(17):2197-200. PubMed ID: 26328646
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?
Dobarro D; Ribera-Solé A
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):345-347. PubMed ID: 32107145
[No Abstract] [Full Text] [Related]
16. Be careful about abdominal discomfort in adult patients with muscular dystrophy.
Fayssoil A; Ritzenthaler T; Luis D; Hullin T; Clair B; Annane D; Orlikowski D
Rev Neurol (Paris); 2014; 170(8-9):548-50. PubMed ID: 25189677
[TBL] [Abstract][Full Text] [Related]
17. Duchenne muscular dystrophy: how bad is the heart?
McNally EM
Heart; 2008 Aug; 94(8):976-7. PubMed ID: 18625791
[No Abstract] [Full Text] [Related]
18. Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
Cheeran D; Khan S; Khera R; Bhatt A; Garg S; Grodin JL; Morlend R; Araj FG; Amin AA; Thibodeau JT; Das S; Drazner MH; Mammen PPA
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042427
[TBL] [Abstract][Full Text] [Related]
19. Myocardial cell damage in Duchenne muscular dystrophy.
Ramaciotti C; Iannaccone ST; Scott WA
Pediatr Cardiol; 2003; 24(5):503-6. PubMed ID: 14627325
[TBL] [Abstract][Full Text] [Related]
20. Is there a future for the use of left ventricular assist devices in Duchenne muscular dystrophy?
Hayes EA; Nandi D
Pediatr Pulmonol; 2021 Apr; 56(4):753-759. PubMed ID: 33245216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
